Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HBeAg-positive Chronic Hepatitis B”

127 trials

Showing 20 of 127 results

Large-scale testing (Phase 3)Study completedNCT03903796
What this trial is testing

Study of the Efficacy and Safety of HS-10234 in Patients With Chronic Hepatitis B Virus Infection

Who this might be right for
Chronic HBV Infection
Jiangsu Hansoh Pharmaceutical Co., Ltd. 963
Large-scale testing (Phase 3)Ended earlyNCT00376259
What this trial is testing

Study of Combination Therapy With LdT Plus Adefovir Versus Adefovir Alone

Who this might be right for
Hepatitis B
Novartis 43
Post-approval studies (Phase 4)Study completedNCT03258710
What this trial is testing

Switching From Entecavir to Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
GlaxoSmithKline 75
Not applicableUnknownNCT02412592
What this trial is testing

Sustained Viral Response in Chronic Hepatitis B Patients Who Achieved HBeAg Seroncongversion After Interferon Therapy

Who this might be right for
Chronic Hepatitis B
Beijing Ditan Hospital 260
Large-scale testing (Phase 3)Study completedNCT00857675
What this trial is testing

A Efficacy and Safety Study of Adefovir Dipivoxil to Treat Chinese Patients With HBeAg+ve Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
GlaxoSmithKline 480
Large-scale testing (Phase 3)Study completedNCT00140725
What this trial is testing

Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV)

Who this might be right for
Chronic Hepatitis B
GlaxoSmithKline 160
Very early researchUnknownNCT03113058
What this trial is testing

"Treatment of Active HBV With γδT Cells" Clinical Trial Protocol

Who this might be right for
Adoptive Treatment for Hepatitis B With γδT Cells
Jinan University Guangzhou 60
Not applicableStudy completedNCT03181113
What this trial is testing

Long-term Benefit in Chronic Hepatitis B Patients After Standard Peginterferon Alfa Therapy

Who this might be right for
Hepatitis B
Xiamen Amoytop Biotech Co., Ltd. 473
Post-approval studies (Phase 4)Study completedNCT01086085
What this trial is testing

Peginterferon Alfa-2a [PEGASYS] in Patients With Chronic Hepatitis B Who Are HBeAg Positive

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 265
Large-scale testing (Phase 3)Study completedNCT01079806
What this trial is testing

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus Infection

Who this might be right for
Chronic Hepatitis B Virus, Pediatric
Bristol-Myers Squibb 180
Post-approval studies (Phase 4)Study completedNCT01088009
What this trial is testing

Efficacy Optimizing Research of Lamivudine Therapy

Who this might be right for
Compensated Chronic Hepatitis B
Nanfang Hospital, Southern Medical University 366
Not applicableStudy completedNCT01734018
What this trial is testing

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive or HBeAg-Negative Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 50
Post-approval studies (Phase 4)Study completedNCT00436163
What this trial is testing

Peginterferon Alfa-2a (40KD) (PEGASYS®) in Participants With Hepatitis B Envelope Antigen (HBeAg) - Positive Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 39
Not applicableStudy completedNCT01581554
What this trial is testing

Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B e Antigen PositiveChronic Hepatitis B e Antigen Negative
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 15
Testing effectiveness (Phase 2)Study completedNCT01326546
What this trial is testing

Therapeutic Hepatitis B Vaccine (Mimogen-based) Joint Entecavir in Treating Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis B
Chongqing Jiachen Biotechnology Ltd. 378
Not applicableEnded earlyNCT00037622
What this trial is testing

Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With Chronic Hepatitis B Infection.

Who this might be right for
Chronic Hepatitis B
Alexion Pharmaceuticals, Inc. 100
Testing effectiveness (Phase 2)WithdrawnNCT06990776
What this trial is testing

A Clinical Trial to Evaluate the Efficacy and Safety of TQA3605 Tablets in Treatment-naive Chronic HBV-infected Subjects

Who this might be right for
Chronic Hepatitis B
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Post-approval studies (Phase 4)Study completedNCT00291616
What this trial is testing

Efficacy Study of Thymosin alpha1 & Pegylated Interferon-alpha2a to Treat Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Seoul National University Hospital 52
Testing effectiveness (Phase 2)Study completedNCT02366208
What this trial is testing

Phase II Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg Positive Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Jiangsu Hansoh Pharmaceutical Co., Ltd. 116
Post-approval studies (Phase 4)UnknownNCT03448744
What this trial is testing

Efficacy and Safety of Combination Therapy of Thymalfasin and Entecavir in HBeAg-positive ETV-experienced Patients

Who this might be right for
Chronic Hepatitis b
Wen-hong Zhang 240
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation